European Union - English - EMA (European Medicines Agency)

olympus biotech international limited - eptotermin alfa - spondylolisthesis - drugs for treatment of bone diseases - opgenra is indicated for posterolateral lumbar spinal fusion in adult patients with spondylolisthesis where autograft has failed or is contra-indicated.

European Union - English - EMA (European Medicines Agency)

olympus biotech international limited - eptotermin alfa - tibial fractures - drugs for treatment of bone diseases, bone morphogenetic proteins - treatment of nonunion of tibia of at least 9 month duration, secondary to trauma, in skeletally mature patients, in cases where previous treatment with autograft has failed or use of autograft is unfeasible.